MedPath

UK First to Release Detailed Data on Clinical Trial Registration Failures

• The UK's Health Research Authority (HRA) has published detailed registration data for 1,545 clinical trials, a pioneering move for transparency. • The data includes trial names, sponsors, and registration numbers, offering unprecedented insight into registration compliance. • In 2022, 92% of trials were registered, showing improvement, with most sponsors informing the HRA of registration. • Two-thirds of the registered trials were found in the U.S. database, ClinicalTrials.gov, highlighting its importance.

The United Kingdom has become the first country to release comprehensive data identifying institutions that have failed to register their clinical trials, a move praised by transparency advocates.
Last week, the Health Research Authority (HRA) posted complete registration information for 1,545 trials. This information includes the name of the study, the sponsor, and the trial's registration number. Previously, the agency only provided annual summaries showing the proportion of trials registered, without publishing trial-by-trial registration specifics.
The 2022 data revealed that 92% of trials had been registered, an increase from previous years, indicating improved compliance. For almost all registered clinical trials, the sponsor had informed the HRA of its registration. Notably, two-thirds of the trials were registered on ClinicalTrials.gov, the U.S. database.
Subscribe Icon

Stay Updated with Our Daily Newsletter

Get the latest pharmaceutical insights, research highlights, and industry updates delivered to your inbox every day.

Related Topics

NWEH and CPRD Partner to Enhance Clinical Trial Recruitment in the UK

NorthWest EHealth (NWEH) and the Clinical Practice Research Datalink (CPRD) are piloting a program to improve clinical trial recruitment using NWEH's FARSITE platform.
The collaboration aims to accelerate participant identification and engagement by integrating CPRD's extensive anonymized patient data with FARSITE's recruitment capabilities.

MHRA Prioritizes National Assessment Route for Innovative Therapies Amidst Rising Drug Filings

The UK's MHRA anticipates a 25% increase in new active substance filings by 2026, necessitating a strategic focus on innovative therapies.
The regulator plans to prioritize the national assessment procedure for at least half of novel drug filings, streamlining the approval process.

UAE's Clinical Trial Landscape Matures with Government Support and Genomic Initiatives

The UAE's clinical research environment is rapidly evolving, supported by new regulatory frameworks and public-private partnerships.
The Emirati Genome Programme aids in identifying patient populations for clinical studies, particularly for rare diseases, using diverse genomic data.

KFSHRC Advances Clinical Trials Through Strategic Partnerships, Enhancing Patient Care

King Faisal Specialist Hospital & Research Centre (KFSHRC) strengthens its clinical research leadership through its Clinical Trials Transformation Initiative, launched in 2021.
In 2023, KFSHRC initiated 140 new clinical trials, providing over 1,200 patients access to innovative therapies and significantly improving patient outcomes.

Clinical Trial Reporting Rates on the Rise Globally, but Gaps Persist

Reporting rates for clinical trials are improving in the EU and the US, driven by stricter regulations and increased awareness.
Compliance varies significantly between countries, with Italy, the Netherlands, Spain, and France lagging in reporting results, especially for publicly funded trials.

HPV Clinical Trial Analysis Reveals Gaps in Prospective Registration and Data Completion

A cross-sectional analysis of 1632 HPV clinical trials registered between 1999 and 2023 reveals inconsistencies in trial registration practices.
The study highlights a significant number of trials registered retrospectively, failing to adhere to prospective registration guidelines.

£400M Investment to Establish Clinical Trial Hubs Across the UK

A £400 million public-private investment will establish up to 18 new clinical trial hubs across the UK to accelerate the development of new medicines.
The investment aims to enhance the UK's clinical trials infrastructure, improve patient recruitment, and provide researchers with access to advanced technology.

NIH Data Shows Improvement in Clinical Trial Results Reporting, but Deadlines Still Missed

NIH data reveals that 41% of clinical trial results were submitted to ClinicalTrials.gov in fiscal year 2022, marking an increase from previous years.
While the vast majority (96%) of trial results are eventually submitted, most are late, with only about one-third submitted by the required due dates.

EU Clinical Trial Regulation Mandates Posting of Interim Results, Raising Transparency Standards

The EU Clinical Trials Regulation will require sponsors to disclose interim clinical trial results, marking a significant shift in transparency.
This new regulation mandates the posting of interim analysis results within specified timelines, impacting clinical operations and data management.

COVID-19 Trial Reporting Lags, Hampering Research Efficiency

A systematic review reveals that the majority of registered COVID-19 trials have not reported results, hindering research progress.
Most published trials focus on hospitalized patients, leaving gaps in outpatient and preventative treatment evidence.

Reference News

[1]
U.K. becomes the first country to release detailed data on sponsors that fail to register clinical trials
statnews.com · Mar 28, 2024

The U.K. released detailed data on clinical trial sponsors failing to register trials, a first for any country. The Heal...

© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy